Literature DB >> 75547

Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes.

J H Russell, A H Hale, L C Ginns, H N Eisen.   

Abstract

During each transplantation passage of a line of mouse myeloma tumor MOPC-315 through syngeneic (BALB/c) hosts, the tumor cells lose reactivity with cytotoxic thymus-derived lymphocytes directed against products of the BALB/c major histocompatibility complex (H-2d) and regain reactivity on transfer to fresh hosts. In contrast to this cyclical change, the tumor cells remain uniformly reactive with anti-H-2d alloantisera throughout the transplantation cycle.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 75547      PMCID： PMC411265          DOI： 10.1073/pnas.75.1.441

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


  17 in total

1.  T-lymphocytes response to Friend virus-induced tumour cell lines in mice of strains congenic at H--2.

Authors:  K J Blank; H A Freedman; F Lilly
Journal:  Nature       Date:  1976-03-18       Impact factor: 49.962

2.  Myeloma cell immunoglobulin expression during in vivo growth in diffusion chambers: evidence for repetitive cycles of differentiation.

Authors:  J W Rohrer; K Vasa; R G Lynch
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

3.  Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes.

Authors:  G M Shearer
Journal:  Eur J Immunol       Date:  1974-08       Impact factor: 5.532

4.  Lymphocyte reactivity to serologically undetected components of the major histocompatibility complex.

Authors:  M B Widmer; B J Alter; F H Bach; M L Bach
Journal:  Nat New Biol       Date:  1973-04-25

5.  Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y.

Authors:  W E Biddison; J C Palmer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

6.  In vivo sensitization of T cells to hapten-conjugated syngeneic structures of major histocompatibility complex. I. Effect of in vitro culture upon generation of cytotoxic T lymphocytes.

Authors:  A Starzinski-Powitz; K Pfizenmaier; M Röllinghoff; H Wagner
Journal:  Eur J Immunol       Date:  1976-11       Impact factor: 5.532

7.  Studies on the specificity of in vitro induced lymphocytotoxicity to SV40-transformed fibroblasts.

Authors:  H Warnatz; F Krapf
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

8.  H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;.

Authors:  R M Zinkernagel; P C Doherty
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

9.  In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice.

Authors:  R D Gordon; E Simpson; L E Samelson
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

10.  Exclusive involvement of H-2Db or H-2Kd product in the interaction between T-killer lymphocytes and syngeneic H-2b or H-2d viral lymphomas.

Authors:  E Gomard; V Duprez; T Reme; M J Colombani; J P Levy
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307
View more
  6 in total

1.  Vesicular stomatitis virus glycoprotein is necessary for H-2-restricted lysis of infected cells by cytotoxic T lymphocytes.

Authors:  A H Hale; O N Witte; D Baltimore; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

2.  Herman N. Eisen: Mentor to many.

Authors:  David M Kranz; Yuri Sykulev
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-23       Impact factor: 11.205

3.  Dissociation of H-2 recognition by antibody and cytotoxic T cells of a cloned murine leukemia cell line.

Authors:  J L Portis; F J McAtee
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

4.  Elicitation of anti-vesicular stomatitis virus cytotoxic T lymphocytes by using purified viral and cellular antigens incorporated into phospholipid vesicles.

Authors:  M J Ruebush; A H Hale; D T Harris
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

5.  Antigen-liposome modification of target cells as a method to alter their susceptibility to lysis by cytotoxic T lymphocytes.

Authors:  A H Hale; M J Ruebush; D S Lyles; D T Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

6.  Variation of expression of histocompatibility antigens on tumor cells: absence of H-2Kk-gene products from a gross-virus-induced leukemia in BALB.K.

Authors:  W Schmidt; L Leben; G Atfield; H Festenstein
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.